$TLX

The 10 most shorted ASX stocks plus the biggest risers and fallers – Week 32

A weekly ASX short-selling recap (data lagged 4 days) lists the 10 most shorted stocks and the biggest changes in short interest. Healius entered the top ten, replacing Treasury Wine. Lotus Resources saw a 57.5% one-day short-interest dip after a $60m raise at 22c. Web Travel Group’s short interest fell ahead of a guidance beat and up to $90m buyback; shares rose 17.1%.

Original reporting
Published Aug 3, 2026, 2:21 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 3, 2026, 5:18 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$TLX
Neutral
low confidence
Mentioned
$TLX · $CAR · $LOT
Relevance
4/10
AlphAI data visualization · based on marketindex.com.au
Decision brief

The 30-second read

$TLXNeutralLow
01

Why it matters

The actionable signal is positioning. The clearest tradable catalyst in the text is Webjet’s 1H26 guidance beat plus an on-market buyback, which coincided with a large same-day rally and declining short interest. For Polynovo, the article links rising shorts to a FY26 trading update that missed consensus and flagged weaker US sales and commercial momentum.

02

Market read

Traders can use the short-interest changes as a sentiment/positioning overlay, but the article itself is not a new fundamental event for most names. The Webjet and Polynovo sections provide the most concrete catalyst linkage to price action and shorting behavior.

03

What to watch

Short-interest reporting is delayed and not mandatory until three business days after trades, so the snapshot may lag the latest fundamental developments and price moves.

Relevance 4/10Novelty 3/10Timing: short-selling data is 4 days behind; useful for positioning into the next session

Background

This is a weekly recap of the most heavily shorted ASX stocks and the biggest week-on-week changes in short interest, using data that lags by four days.

Company-level read

Ticker impact

$TLXNeutralLow confidence
Context

Telix Pharmaceuticals is in the most shorted group, with short interest essentially unchanged week-on-week (-0.01%) but down month-on-month (-0.56%).

Expected impact

Potential for stabilization rather than fresh downside.

Evidence & confidence

The article provides short-interest deltas only; without new trial or guidance details, the signal is weak.

$CARNeutralLow confidence
Context

CAR Group is listed among the most shorted ASX stocks, with short interest down 0.12% week-on-week.

Expected impact

Mild upward drift possible if the trend continues.

Evidence & confidence

The article does not provide a new CAR-specific fundamental catalyst, only short-interest movement.

$LOTNeutralLow confidence
Context

Lotus Resources remains among the most shorted, with short interest 22.49% and week-on-week -0.31%, month-on-month -0.33%.

Expected impact

High volatility risk remains due to elevated short %, but direction is unclear from the small declines.

Evidence & confidence

The article notes a prior one-day dip tied to a $60m raise at 22 cents, but the newest disclosed changes are modest WoW/MoM.

Market effects

Signals shifting sentiment across ASX healthcare, travel, and industrials, but without sector-wide regulatory or macro triggers.

Primarily affects Australian small-to-mid caps where short interest is meaningful; limited spillover to broader ASX indices implied.

Low, as the catalyst set is company-specific short-interest and guidance/buyback details for ASX-listed names.

Counterpoint

Rising short interest can coincide with oversold conditions; if the market is already pricing bad news, shorts may be late and vulnerable to squeezes.

Key entities

  • Webjet (Web Travel Group)

    Guidance update on 29 July topped revenue margin and FY26 EBITDA expectations, with an on-market buyback up to $90m; stock rallied 17.1% on the day.

  • Polynovo

    FY26 trading update on 23 July showed sales up 21.1% to $102.1m but short of consensus, with second-half US slowdown commentary; short interest rebuilt to 9.58%.

  • Healius

    Joined the top ten most shorted, with short interest up 0.55% week-on-week and 0.52% month-on-month.

  • Lotus Resources

    Remains highly shorted at 22.49% short %, with the article referencing a prior $60m raise at 22 cents per share tied to a one-day dip.

Related articles

$CARMedAI 8/10

What Could Send Avis Budget Stock Higher?

Avis Budget (CAR) shares have dropped 85.7% from their April high. The company expects a $650 million cash payment from Pentwater by year-end to reduce debt. Total debt is 805% of market value, but management aims to lower leverage. Operating income improved to $572 million in the past year, yet shares fell 31.9% over the year.

$TLXHighAI 9/10

Telix Reports Third Quarter 2026 Financial Performance

Telix Pharmaceuticals reported Q3 2026 revenue of $245M, up 19% YoY, driven by strong demand for its PSMA products. Precision Medicine revenue grew 30% to $201M. The FDA approved Pixclara for glioma imaging, and the company completed BiPASS study enrollment. Telix also announced a merger with ITM, expecting FY 2026 revenue to exceed $1B.

$TLXMed

A scarce radioactive material studied for cancer treatment could be made in the U.S.

Telix Pharmaceuticals and Ekalia (a joint venture between IBA and Framatome) are collaborating to establish U.S. production of astatine-211 (211At), a rare radioisotope for cancer treatment. The partnership will use IBA's cyclotron technology and Telix's U.S. radiopharmacy infrastructure. Telix aims to advance its alpha therapy pipeline, including TLX102-Tx for glioblastoma, and support third-party research.